Schellens JHM - Search Results

1

A cost analysis of upfront DPYD genotype-guided dose individualisation in fluoropyrimidine-based anticancer therapy.

Henricks LM, Lunenburg CATC, de Man FM, Meulendijks D, Frederix GWJ, Kienhuis E, Creemers GJ, Baars A, Dezentjé VO, Imholz ALT, Jeurissen FJF, Portielje JEA, Jansen RLH, Hamberg P, Ten Tije AJ, Droogendijk HJ, Koopman M, Nieboer P, van de Poel MHW, Mandigers CMPW, Rosing H, Beijnen JH, van Werkhoven E, van Kuilenburg ABP, van Schaik RHN, Mathijssen RHJ, Swen JJ, Gelderblom H, Cats A, Guchelaar HJ, Schellens JHM. Henricks LM, et al. Among authors: schellens jhm. Eur J Cancer. 2019 Jan;107:60-67. doi: 10.1016/j.ejca.2018.11.010. Epub 2018 Dec 11. Eur J Cancer. 2019. PMID: 30544060

2

The combined use of radiotherapy and chemotherapy in the treatment of solid tumours.

Bartelink H, Schellens JH, Verheij M. Bartelink H, et al. Eur J Cancer. 2002 Jan;38(2):216-22. doi: 10.1016/s0959-8049(01)00363-x. Eur J Cancer. 2002. PMID: 11803138 Review.

3

Entrapment by Cremophor EL decreases the absorption of paclitaxel from the gut.

Bardelmeijer HA, Ouwehand M, Malingré MM, Schellens J, Beijnen JH, van Tellingen O. Bardelmeijer HA, et al. Cancer Chemother Pharmacol. 2002 Feb;49(2):119-25. doi: 10.1007/s00280-001-0394-2. Epub 2001 Nov 20. Cancer Chemother Pharmacol. 2002. PMID: 11862425

4

Topoisomerase I levels in white blood cells of patients with ovarian cancer treated with paclitaxel-cisplatin-topotecan in a phase I study.

Schoemaker NE, Herben VM, de Jong LA, van Waardenburg RC, Pluim D, ten Bokkel Huinink WW, Beijnen JH, Schellens JH. Schoemaker NE, et al. Anticancer Drugs. 2002 Jan;13(1):87-91. doi: 10.1097/00001813-200201000-00010. Anticancer Drugs. 2002. PMID: 11914645

5

Clinical pharmacology of the novel marine-derived anticancer agent Ecteinascidin 743 administered as a 1- and 3-h infusion in a phase I study.

van Kesteren C, Twelves C, Bowman A, Hoekman K, López-Lázaro L, Jimeno J, Guzman C, Mathôt RA, Simpson A, Vermorken JB, Smyth J, Schellens JH, Hillebrand MJ, Rosing H, Beijnen JH. van Kesteren C, et al. Anticancer Drugs. 2002 Apr;13(4):381-93. doi: 10.1097/00001813-200204000-00007. Anticancer Drugs. 2002. PMID: 11984084 Clinical Trial.

6

Evaluation of the bioequivalence of tablets and capsules containing the novel anticancer agent R115777 (Zarnestra) in patients with advanced solid tumors.

Crul M, de Klerk GJ, Swart M, Weiner L, Palmer PA, Bol CJ, Beijnen JH, Schellens JH. Crul M, et al. Eur J Drug Metab Pharmacokinet. 2002 Jan-Mar;27(1):61-5. doi: 10.1007/BF03190407. Eur J Drug Metab Pharmacokinet. 2002. PMID: 11996329 Clinical Trial.

7

Acute poisoning after oral intake of a toluene-containing paint thinner.

Malingré MM, Hendrix EA, Schellens JH, Koks CH, Tibben MM, Challa EE, Beijnen JH. Malingré MM, et al. Eur J Pediatr. 2002 Jun;161(6):354-5. doi: 10.1007/s00431-001-0889-1. Epub 2002 Apr 16. Eur J Pediatr. 2002. PMID: 12029459 No abstract available.

8

Increased oral bioavailability of topotecan in combination with the breast cancer resistance protein and P-glycoprotein inhibitor GF120918.

Kruijtzer CM, Beijnen JH, Rosing H, ten Bokkel Huinink WW, Schot M, Jewell RC, Paul EM, Schellens JH. Kruijtzer CM, et al. J Clin Oncol. 2002 Jul 1;20(13):2943-50. doi: 10.1200/JCO.2002.12.116. J Clin Oncol. 2002. PMID: 12089223 Clinical Trial.

9

Determination of total platinum in plasma and plasma ultrafiltrate, from subjects dosed with the platinum-containing N-(2-hydroxypropyl)methacrylamide copolymer AP5280, by use of graphite-furnace Zeeman atomic-absorption spectrometry.

Tibben MM, Rademaker-Lakhai JM, Rice JR, Stewart DR, Schellens JH, Beijnen JH. Tibben MM, et al. Anal Bioanal Chem. 2002 Jul;373(4-5):233-6. doi: 10.1007/s00216-002-1340-9. Epub 2002 Jun 6. Anal Bioanal Chem. 2002. PMID: 12110973

10

A population analysis of the pharmacokinetics of Cremophor EL using nonlinear mixed-effect modelling.

van den Bongard HJ, Mathôt RA, van Tellingen O, Schellens JH, Beijnen JH. van den Bongard HJ, et al. Cancer Chemother Pharmacol. 2002 Jul;50(1):16-24. doi: 10.1007/s00280-002-0459-x. Epub 2002 May 1. Cancer Chemother Pharmacol. 2002. PMID: 12111107

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

754 results

Search Page

Filters